179 filings
Page 5 of 9
8-K
p3eeuaih7i8j92i2j
28 Jun 18
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
by6cbr
18 Jun 18
Submission of Matters to a Vote of Security Holders
5:08pm
8-K
wk6 ozfigo
18 Apr 18
Regulation FD Disclosure
12:00am
8-K
sc13eyfde68 bhftb
8 Feb 18
Haichang to fund development through completion of Phase IIa Proof-of-Concept Clinical Trial
12:00am
8-K
1tyq5i
19 Jan 18
Regulation FD Disclosure
12:00am
8-K
8zio8g8p
4 Jan 18
Rexahn Pharmaceuticals Announces the Appointment of Douglas J. Swirsky as President and Chief Financial Officer
12:00am
8-K
b3u6uy15b9jvgtbovqpj
21 Dec 17
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
12:00am
8-K
3c2sum511wjnznpo
12 Dec 17
Departure of Directors or Certain Officers
12:00am
8-K
9fqq0ty
17 Oct 17
Other Events
12:00am
8-K
3ga2q7zqweb6
13 Oct 17
Entry into a Material Definitive Agreement
12:00am
8-K
gczw5i
1 Sep 17
Rexahn Pharmaceuticals Announces Retirement of its Founder, Chang Ahn, Ph.D., from the Board of Directors
12:00am
8-K
4jqvqky
12 Jun 17
Other Events
12:00am
8-K
32u de3ch4u8
7 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
85o4wowg3
5 May 17
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
07syqa3lp4
13 Apr 17
Rexahn Announces 1-for-10 Reverse Stock Split
12:00am
8-K
8hli g4hf19sgr9
25 Nov 16
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
12:00am
8-K
kigwgbcshg9n6jgmw65
20 Sep 16
Other Events
12:00am
8-K
5w2if1
14 Sep 16
Entry into a Material Definitive Agreement
12:00am
8-K
psdxd ygeh486j
12 Sep 16
Regulation FD Disclosure
12:00am
8-K
j1dct6d2 ni2oberhimy
11 Jul 16
Rexahn Pharmaceuticals Strengthens Leadership Team
12:00am